Policy recommendations on uptake of biosimilar medicines in the retail market

5 November 2021

Policy

Policy recommendations on uptake of biosimilar medicines in the retail […]

Positioning Statements on Physician-led Switching for Biosimilar Medicines

1 October 2021

Policy

Positioning statements on physician-led switching for biosimilar medicines (October 2021) […]

The Issue of Abuses of Divisional Patent Application

30 April 2021

Policy

EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply

17 March 2021

Policy

Position Paper – Unitary SPC & Unified Mechanism for the Granting of SPCs

15 March 2021

Policy

Medicines for Europe Position on IP Action Plan – March 2021

13 March 2021

Policy

Maintaining the exchange of critical health data – An adequacy decision on the UK data protection regime

5 March 2021

Policy

Medicines for Europe Position Paper On Patent Linkage

3 March 2021

Policy

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2021

Policy

Medicines for Europe Position Paper on Bolar Exemption – Feb 2021

15 February 2021

Policy